3Q2022

Supplemental Information

FURNISHED AS OF NOVEMBER 9, 2022 - UNAUDITED

FORWARD LOOKING STATEMENTS & RISK FACTORS

This Supplemental Information report contains disclosures that are “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words and phrases such as “can,” “may,” “payable,” “indicative,” "predictive," “annualized,” “expect,” “expected,” “range of expectations,” "would have been," "budget," and other comparable terms in this report, and include, but are not limited to, statements related to the merger between Healthcare Realty Trust Incorporated (“Legacy HR” and, after the closing of the merger, the “Company”) and Healthcare Trust of America, Inc. (“Legacy HTA”) that closed on July 20, 2022 (the “Merger”). These forward-looking statements are made as of the date of this report and are not guarantees of future performance. These statements are based on the current plans and expectations of Company management and are subject to a number of unknown risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those described in this release or implied by such forward-looking statements. Such risks and uncertainties include, among other things, the following: risks related to the Merger diverting the attention the Company's management from ongoing business operations; failure to realize the expected benefits of the Merger; the risk that the Company’s and Legacy HTA’s respective businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; and other legal and operational matters. Other risks, uncertainties and factors that could cause actual results to differ materially from those projected are detailed under the heading “Risk Factors,” in the Legacy HR’s and Legacy HTA’s Annual Reports on Form 10-K filed with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2021, under the heading "Risk Factors" and other risks described from time to time thereafter in the Legacy HR’s. Legacy HTA’s, and the Company's SEC filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Table of Contents

4			Highlights
6			Salient Facts
7			Corporate Information
8			Balance Sheet
9			Statements of Income
10			FFO, Normalized FFO, & FAD
11			Capital Funding & Commitments
12			Debt Metrics
13			Debt Covenants & Liquidity
14			Investment Activity
15			Re/development Activity
16			Portfolio
17			Health Systems
18			MOB Proximity to Hospital
19			Lease Maturity & Occupancy
20			Leasing Statistics
21			NOI Performance
22			NOI Reconciliations
24			EBITDA Reconciliations
25			Components of Net Asset Value

Copies of this report may be obtained at www.healthcarerealty.com or by contacting Investor Relations at 615.269.8175 or communications@healthcarerealty.com.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 3

Highlights

QUARTERLY HIGHLIGHTS

•The Company completed the merger with Healthcare Trust of America, Inc. on July 20, 2022. Legacy HR was the accounting acquirer in the reverse merger structure. Unless otherwise noted, all financial information prior to the completion of the merger relates to Legacy HR.

•Net income attributable to common stockholders for the three months ended September 30, 2022 was $28.3 million or $0.08 per diluted common share.

•Normalized FFO per share totaled $0.39. With the full quarter pro-forma and run-rate adjustments as outlined below, expected run-rate normalized FFO is $0.40 per share. These quarterly amounts include the negative effect of non-cash, merger-related fair value debt adjustments of $0.03 per share. See the section below for a reconciliation of these items.

•Same store cash NOI for the third quarter increased 2.8% over the prior year. For the trailing twelve months ended September 30, 2022, same store cash NOI grew 2.4%. The same store portfolio includes 589 properties from combined Legacy HR and HTA, comprising 83% of total cash NOI.

•Predictive growth measures in the same store portfolio include:

◦Average in-place rent increases of 2.64%

◦Future annual contractual increases of 2.8% for leases commencing in the quarter

◦Weighted average cash leasing spreads of 2.9% on 634,000 square feet renewed:

▪10% (<0% spread)

▪26% (0-3%)

▪43% (3-4%)

▪22% (>4%)

◦Tenant retention of 79.1%

•Portfolio leasing activity in the third quarter totaled 1,086,000 square feet related to 317 leases:

◦694,000 square feet of renewals

◦392,000 square feet of new and expansion leases

•In the third quarter, the Company realized $16.4 million of annualized synergies, or nearly half of the projected $33-$36 million of annual G&A synergies. The Company expects to realize approximately $18 million of remaining annual G&A savings evenly over the next three quarters. This equates to an incremental $1.5 million of G&A savings for each of the next three quarters.

•Associated with the merger, the Company has closed $922 million in joint ventures and asset sale transactions at a weighted average cap rate of 4.6%. Transactions totaling $105 million are under contract and expected to close in November. In December, the Company expects to complete the remaining sales that will bring the total to over $1.1 billion at an expected weighted average cap rate of 4.8%.

•Since the end of the second quarter, the Company acquired nine medical office buildings totaling 249,000 square feet for $94.9 million. The properties are all located in existing markets and expand clusters in high growth markets, including Atlanta, Nashville and Raleigh.

•Since the end of the third quarter, the Company entered into new interest rate swaps totaling $250 million, bringing fixed rate debt to 86% of total debt, excluding the remaining balance on the asset sale term loan.

•Run-rate net debt to adjusted EBITDA on a full quarter proforma basis was 6.3 times at the end of the quarter. For a reconciliation to expected run-rate amounts, see the section below.

•A dividend of $0.31 per share will be paid on November 30, 2022 to stockholders of record on November 15, 2022.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 4

RUN-RATE ADJUSTED EBITDA, NORMALIZED FFO AND FAD

The following table provides a reconciliation of the current quarter full proforma normalized FFO, FAD and Adjusted EBITDA to an expected quarterly run-rate. The expected run-rates do not adjust for future changes in interest rates, portfolio NOI growth, or external investment activity. The expected run-rates also do not include any dispositions beyond those expected to repay the $1.125 billion asset sale term loan.

			NORMALIZED FFO			FAD			ADJUSTED EBITDA			NET DEBT
Q3 2022 proforma full quarter			$150,884			$118,835			$212,759			$5,840,802
NOI adjustments for asset sales: 1
Q3 NOI recognized on assets sold during the quarter 2			(3,997)			(3,944)			—			—
October asset sales completed			(1,625)			(1,600)			(1,625)			(136,000)
Expected November asset sales			(1,400)			(1,300)			(1,400)			(105,000)
Expected December asset sales			(3,000)			(2,875)			(3,000)			(182,000)
Q3 acquisition timing 2			918			865			—			—
Q3 recognized interest expense on the asset sale term loan			5,419			5,151			—			—
Reversal of Q3 seasonal utilities			2,500			2,500			2,500			—
Remaining expected G&A synergies 3			4,500			4,500			4,500			—
Normalized maintenance capex 4			—			4,500			—			—
Adjusted run-rate			$154,199			$126,632			$213,734			$5,417,802
Per share			$0.40			$0.33
Net debt to adjusted EBITDA												6.3x
FFO wtd avg common shares outstanding - diluted			384,615			384,615
Merger-related fair value debt adjustment			$11,844
Per share			$0.03

1FFO and EBITDA includes the impact of straight-line rent.

2Adjustments to reflect quarterly NOI/EBITDA from properties acquired or disposed of in the quarter.

3The Company expects to realize $1.5 million per quarter in incremental G&A savings over each of the next three quarters.

4Quarterly maintenance capex as a percentage of NOI was 17.6%. The Company expects a run rate of 16% of run-rate adjusted cash NOI.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 5

Salient Facts 1

AS OF SEPTEMBER 30, 2022

			Properties
			728 properties totaling 42.6M SF
			71 markets in 35 states
			38.9M SF managed by Healthcare Realty
			91.8% medical office and outpatient
			60% of NOI in Top Markets
			Capitalization
			$13.8B enterprise value as of 9/30/22
			$7.9B market capitalization as of 9/30/22
			384.6M shares outstanding (including OP units)
			$0.31 quarterly dividend per share
			BBB/Baa2/BBB S&P/Moody's/Fitch
			42.4% net debt to enterprise value at 9/30/22
			6.3x proforma net debt to adjusted EBITDA

1 Includes properties held in joint ventures.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 6

Corporate Information

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2022, the Company was invested in 728 real estate properties in 35 states totaling 42.6 million square feet and had an enterprise value of approximately $13.8 billion, defined as equity market capitalization plus the principal amount of debt less cash. The Company provided leasing and property management services to 38.9 million square feet nationwide.

EXECUTIVE OFFICERS

Todd J. Meredith

President and Chief Executive Officer

John M. Bryant, Jr.

Executive Vice President and General Counsel

J. Christopher Douglas

Executive Vice President and Chief Financial Officer

Robert E. Hull

Executive Vice President - Investments

Julie F. Wilson

Executive Vice President - Operations

ANALYST COVERAGE

BMO Capital Markets

BTIG, LLC

CapitalOne Securities, Inc.

Citi Research

Credit Suisse Securities (USA) LLC

Green Street Advisors, Inc.

J.P. Morgan Securities LLC

Jefferies LLC

KeyBanc Capital Markets Inc.

Raymond James & Associates

Scotiabank

SMBC Nikko Securities America, Inc.

Stifel, Nicolaus & Company, Inc.

BOARD OF DIRECTORS

J. Knox Singleton    

Chairman, Healthcare Realty Trust Incorporated

Retired Chief Executive Officer, Inova Health System

W. Bradley Blair, II

Vice Chairman, Healthcare Realty Trust Incorporated

Retired Chairman, Healthcare Trust of America

Todd J. Meredith

President and Chief Executive Officer

Healthcare Realty Trust Incorporated

John V. Abbott

Retired Chief Executive Officer

Aviation Asset Management Group, General Electric Company

Nancy H. Agee

President and Chief Executive Officer

Carilion Clinic

Vicki U. Booth

President and Board Chair

Ueberroth Family Foundation

Edward H. Braman

Retired Audit Partner

Ernst & Young LLP

Ajay Gupta

Chief Executive Officer

Physician Rehabilitation Network

James J. Kilroy

President and Portfolio Manager

Willis Investment Counsel

Jay P. Leupp

Managing Partner and Senior Portfolio Manager

Terra Firma Asset Management, LLC

Peter F. Lyle

Executive Vice President

Medical Management Associates, Inc.

Constance B. Moore

Retired President and CEO

BRE Properties, Inc.

Christann M. Vasquez

Executive Vice President and Chief Operating Officer

Ascension Texas

David R. Emery (1944-2019)

Chairman Emeritus

Healthcare Realty Trust Incorporated

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 7

Balance Sheet

AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA

ASSETS
						2Q 2022
			3Q 2022			Combined			Legacy HR									Legacy HTA
Real estate properties
Land			$1,449,550			$1,104,700			$456,306									$648,394
Buildings and improvements			11,439,797			11,447,844			4,673,026									6,774,818
Lease intangibles			968,914			382,738			—									382,738
Personal property			11,680			11,799			11,799									—
Investment in financing receivables, net			118,919			118,446			118,446									—
Financing lease right-of-use assets			79,950			71,632			71,632									—
Construction in progress			43,148			31,980			16,728									15,252
Land held for development			73,321			22,952			22,952									—
Total real estate investments			14,185,279			13,192,091			5,370,889									7,821,202
Less accumulated depreciation and amortization			(1,468,736)			(3,102,055)			(1,402,509)									(1,699,546)
Total real estate investments, net			12,716,543			10,090,036			3,968,380									6,121,656
Cash and cash equivalents			57,583			64,026			34,312									29,714
Restricted cash			—			4,559			—									4,559
Assets held for sale, net			185,074			—			—									—
Operating lease right-of-use assets			321,365			353,807			126,204									227,603
Investments in unconsolidated joint ventures			327,752			272,851			210,781									62,070
Other assets, net and goodwill			587,126			578,948			209,200									369,748
Total assets			$14,195,443			$11,364,227			$4,548,877									$6,815,350
LIABILITIES AND STOCKHOLDERS' EQUITY
						2Q 2022
			3Q 2022			Combined			Legacy HR									Legacy HTA
Liabilities
Notes and bonds payable			$5,570,139			$5,158,398			$2,063,755									$3,094,643
Accounts payable and accrued liabilities			231,018			255,883			84,210									171,673
Liabilities of properties held for sale			10,644			—			—									—
Operating lease liabilities			268,840			291,739			94,748									196,991
Financing lease liabilities			72,378			62,195			62,195									—
Other liabilities			203,398			176,844			66,102									110,742
Total liabilities			6,356,417			5,945,059			2,371,010									3,574,049
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized			—			—			—									—
Common stock, $0.01 par value; 1,000,000 shares authorized			3,806			3,807			1,516									2,291
Additional paid-in capital			9,586,556			9,185,292			4,002,526									5,182,766
Accumulated other comprehensive income/(loss)			5,524			4,536			(1,250)									5,786
Cumulative net income attributable to common stockholders			1,342,819			1,314,515			1,314,515									—
Cumulative dividends 1			(3,211,492)			(5,171,621)			(3,139,440)									(2,032,181)
Total stockholders' equity			7,727,213			5,336,529			2,177,867									3,158,662
Non-controlling interest			111,813			82,639			—									82,639
Total Equity			7,839,026			5,419,168			2,177,867									3,241,301
Total liabilities and stockholders' equity			$	14,195,443		$	11,364,227		$	4,548,877								$	6,815,350

1Includes Legacy HTA's cumulative dividends in excess of earnings.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 8

Statements of Income1

DOLLARS IN THOUSANDS

			3Q 2022						2Q 2022
			AS REPORTED			PROFORMA FULL QUARTER			COMBINED			LEGACY HR			LEGACY HTA
Revenues
Rental income			298,931			344,251			338,916			140,632			198,284
Interest income			3,366			3,750			1,957			1,957			—
Other operating			4,057			4,057			4,587			2,738			1,849
			306,354			352,058			345,460			145,327			200,133
Expenses
Property operating			112,473			127,172			120,383			57,010			63,373
General and administrative			16,741			18,956			24,783			10,540			14,243
Acquisition and pursuit costs 2			482			482			1,449			1,352			97
Merger-related costs			79,402			79,402			12,192			7,085			5,107
Depreciation and amortization			158,117			186,643			130,782			55,731			75,051
			367,215			412,655			289,589			131,718			157,871
Other income (expense)
Interest expense before merger-related fair value			($43,775)			($48,547)			($40,303)			($15,543)			($24,760)
Merger-related fair value adjustment			(9,269)			(11,844)			—			—			—
Interest expense			(53,044)			(60,391)			(40,303)			(15,543)			(24,760)
Gain on sales of real estate properties			143,908			143,908			8,496			8,496			—
Loss on extinguishment of debt			(1,091)			(1,091)			(3,615)			—			(3,615)
Equity loss from unconsolidated joint ventures			(124)			(124)			94			(307)			401
Interest and other income (expense), net			(172)			(172)			9			(125)			134
			89,477			82,130			(35,319)			(7,479)			(27,840)
Net income			$28,616			$21,533			$20,552			$6,130			$14,422
Net income attributable to non-controlling interests			(312)			(316)			(254)			—			(254)
Net income attributable to common stockholders			$28,304			$21,217			$20,298			$6,130			$14,168
MERGER-RELATED NON-CASH FAIR VALUE DEBT ADJUSTMENT
						PROFORMA FULL QUARTER			PER SHARE
Merger-related non-cash fair value debt adjustment						$(11,844)			($0.031)
G&A SYNERGIES
						QUARTERLY AMOUNT			PER SHARE
Q2 2022 combined						$24,783
Legacy HTA normalizing adjustments						(1,700)
Q2 2022 normalized combined						23,083
Q3 2022 realized synergies						(4,127)			($0.011)
Q3 2022 proforma full quarter						18,956
Remaining expected synergies						(4,500)			($0.012)

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Includes third party and travel costs related to the pursuit of acquisitions and developments.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 9

FFO, Normalized FFO, & FAD 1,2,3

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

			3Q 2022						2Q 2022
			AS REPORTED			PROFORMA FULL QUARTER			COMBINED			LEGACY HR			LEGACY HTA9
Net income attributable to common stockholders			$28,304			$21,217			$20,298			$6,130			$14,168
Gain on sales of real estate assets			(143,908)			(143,908)			(8,496)			(8,496)			—
Real estate depreciation and amortization			159,643			188,131			131,778			57,334			74,444
Non-controlling income from partnership units			377			316			254			—			254
Unconsolidated JV depreciation and amortization			3,526			3,526			3,295			2,807			488
FFO			$47,942			$69,282			$147,129			$57,775			$89,354
Acquisition and pursuit costs 4			482			482			1,449			1,352			97
Merger-related costs			79,402			79,402			12,192			7,085			5,107
Lease intangible amortization			(2)			127			815			584			231
Non-routine legal costs/forfeited earnest money received 5			346			346			1,842			140			1,702
Debt financing costs			1,091			1,091			4,716			—			4,716
Unconsolidated JV normalizing items 6			154			154			83			83			—
Normalized FFO			$129,415			$150,884			$168,226			$67,019			$101,207
Non-real estate depreciation and amortization			577			577			1,780			556			1,224
Non-cash interest amortization 7			8,924			11,499			747			747			—
Provision for bad debt, net			457			457			16			16			—
Straight-line rent income, net			(7,715)			(9,908)			(3,743)			(1,327)			(2,416)
Stock-based compensation			3,666			3,666			5,547			3,356			2,191
Unconsolidated JV non-cash items 8			(377)			(377)			(242)			(242)			—
Normalized FFO adjusted for non-cash items			134,947			156,798			172,331			70,125			102,206
2nd generation TI			(10,147)			(11,763)			(13,635)			(5,051)			(8,584)
Leasing commissions paid			(8,283)			(8,739)			(7,251)			(3,475)			(3,776)
Capital expenditures			(16,067)			(17,461)			(11,726)			(4,557)			(7,169)
Total maintenance capex			(34,497)			(37,963)			(32,612)			(13,083)			(19,529)
FAD			$100,450			$118,835			$139,719			$57,042			$82,677
Quarterly dividends 9			$103,174			$119,194			$122,862			$47,097			$75,765
FFO per common share - diluted			$0.14			$0.18			$0.38			$0.38			$0.38
Normalized FFO per common share - diluted			$0.39			$0.39			$0.44			$0.45			$0.43
FFO wtd avg common shares outstanding - diluted 10			332,819			384,615			383,670			150,545			233,125

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”

3FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with accounting principles generally accepted in the United States of America and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.

4Acquisition and pursuit costs include third party and travel costs related to the pursuit of acquisitions and developments.

5Non-routine legal costs include expenses related to two separate disputes: one with a contractor on a $60.6 million completed construction project and another with a tenant on a violation of use restrictions. Forfeited earnest money received related to a disposition that did not materialize.

6Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.

7Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.

8Includes the Company's proportionate share of straight-line rent, net and provision for bad debt, net related to unconsolidated joint ventures.

9Quarterly dividends for the third quarter represent dividends at the current rate of $0.31 per share multiplied by the weighted average shares outstanding. Actual dividends paid in the third quarter were $72.1 million.

10The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 787,559 for the three months ended September 30, 2022.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 10

Capital Funding & Commitments 1

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

ACQUISITION AND RE/DEVELOPMENT FUNDING
			PROFORMA 3Q 2022			2Q 2022			1Q 2022			4Q 2021			3Q 2021
Acquisitions 2			$91,253			$163,762			$172,663			$258,072			$160,073
Re/development			31,546			9,387			7,664			11,767			6,594
1st generation TI & acquisition capex 3			12,596			8,103			7,473			7,596			4,675
MAINTENANCE CAPITAL EXPENDITURES FUNDING
			PROFORMA 3Q 2022			2Q 2022			1Q 2022			4Q 2021			3Q 2021
2nd generation TI			$11,763			$5,051			$4,899			$10,207			$6,219
Leasing commissions paid			8,739			3,475			3,767			2,214			4,531
Capital expenditures			17,461			4,557			2,620			6,043			5,443
			$37,963			$13,083			$11,286			$18,464			$16,193
% of Cash NOI
2nd generation TI			5.5		%	5.6		%	5.6		%	12.1		%	7.6		%
Leasing commissions paid			4.1		%	3.9		%	4.3		%	2.6		%	5.6		%
Capital expenditures			8.1		%	5.1		%	3.0		%	7.2		%	6.7		%
			17.6		%	14.5		%	13.0		%	22.0		%	19.9		%
LEASING COMMITMENTS
			PROFORMA 3Q 2022			2Q 2022			1Q 2022			4Q 2021			3Q 2021
Renewals
Square feet			632,690			205,400			260,202			332,819			360,302
2nd generation TI/square foot/lease year			$1.66			$1.66			$1.73			$1.46			$1.75
Leasing commissions/square foot/lease year			$1.03			$1.15			$1.04			$1.23			$0.93
Renewal commitments as a % of annual net rent			10.5		%	11.4		%	11.0		%	11.4		%	11.4		%
WALT (in months) 4			50.1			39.7			42.9			46.4			45.0
New leases
Square feet			262,904			79,467			96,001			109,592			97,619
2nd generation TI/square foot/lease year			$4.84			$7.07			$5.93			$5.44			$4.74
Leasing commissions/square foot/lease year			$1.39			$1.65			$1.90			$1.84			$1.62
New lease commitments as a % of annual net rent			28.1		%	40.6		%	32.2		%	34.2		%	30.7		%
WALT (in months) 4			87.1			77.4			76.9			77.2			80.0
All
Square feet			895,594			284,867			356,203			442,411			457,921
Leasing commitments as a % of annual net rent			16.9		%	22.6		%	19.2		%	18.8		%	16.8		%
WALT (in months) 4			61.0			50.2			52.1			54.0			52.5

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Acquisitions include properties acquired through joint ventures at the Company's ownership percentage.

3Acquisition capex includes near-term fundings underwritten as part of recent acquisitions.

4WALT = weighted average lease term.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 11

Debt Metrics1

DOLLARS IN THOUSANDS

AS REPORTED

SUMMARY OF INDEBTEDNESS AS OF SEPTEMBER 30, 2022
			PRINCIPAL BALANCE			BALANCE 2			MATURITY DATE			MONTHS TO MATURITY 3			INTEREST EXPENSE			CONTRACTUAL INTEREST EXPENSE			CONTRACTUAL RATE			EFFECTIVE RATE			FAIR VALUE MERGER ADJUSTED
SENIOR NOTES			$250,000			$249,025			5/1/2025			31			$2,470			$2,422			3.88		%	4.12		%
			600,000			569,786			8/1/2026			46			5,606			4,200			3.50		%	4.94		%	Y
			500,000			478,541			7/1/2027			57			4,541			3,750			3.75		%	4.76		%	Y
			300,000			296,711			1/15/2028			64			2,780			2,719			3.63		%	3.85		%
			650,000			562,974			2/15/2030			89			5,867			3,974			3.10		%	5.30		%	Y
			300,000			296,787			3/15/2030			90			1,930			1,800			2.40		%	2.72		%
			300,000			295,424			3/15/2031			102			1,591			1,537			2.05		%	2.25		%
			800,000			628,617			3/15/2031			102			6,334			3,155			2.00		%	5.13		%	Y
			$3,700,000			$3,377,865						74			$31,119			$23,557			2.97		%	4.42		%
TERM LOANS			$350,000			$348,735			7/20/2025			34			$80			$80			SOFR + 1.05%			4.10		%
			200,000			199,611			5/31/2026			44			1,701			1,701			SOFR + 1.05%			3.51		%
			300,000			299,930			10/31/2026			49			1,541			1,541			SOFR + 1.05%			2.47		%
			150,000			149,458			5/31/2026			44			1,251			1,251			SOFR + 1.05%			3.32		%
			200,000			199,328			7/1/2027			57			984			984			SOFR + 1.05%			2.27		%
			300,000			297,764			1/12/2028			63			2,077			2,077			SOFR + 1.05%			3.56		%
			$1,500,000			$1,494,826						48			$7,634			$7,634						3.26		%
$1.5B CREDIT FACILITY			$190,600			$190,600			10/31/2027			61			$4,046			$4,046			SOFR + 0.95%			3.99		%
$1.125B ASSET SALE TERM			$423,000			$421,919			7/19/2024			22			$5,419			$5,151			SOFR + 1.05%			4.07		%	Y
MORTGAGES			$84,784			$84,929			various			27			$803			$867			4.07		%	3.97		%
			$5,898,384			$5,570,139						62			$49,021			$41,255			3.17		%	4.06		%
Interest cost capitalization															(703)			—
Unsecured credit facility fee & deferred financing costs															2,105			764
Fair value derivative amortization															1,732			—
Financing right-of-use asset amortization															889			—
															$53,044			$42,019

DEBT MATURITIES SCHEDULE AS OF SEPTEMBER 30, 2022
						PRINCIPAL PAYMENTS															WEIGHTED AVERAGE CONTRACTUAL RATE
						BANK LOANS			SENIOR NOTES			MORTGAGE NOTES			TOTAL						BANK LOANS			SENIOR NOTES			MORTGAGE NOTES			TOTAL
2022												$661			$661						—		%	—		%	4.00		%	4.00		%
2023												18,880			18,880						—		%	—		%	3.83		%	3.83		%
2024						$423,000						25,353			448,353						4.07		%	—		%	4.41		%	4.09		%
2025						350,000			$250,000			16,250			616,250						4.10		%	3.88		%	4.22		%	4.01		%
2026						650,000			600,000			23,640			1,273,640						2.98		%	3.50		%	3.81		%	3.24		%
2027						390,600			500,000						890,600						3.11		%	3.75		%	—		%	3.47		%
2028						300,000			300,000						600,000						3.56		%	3.63		%	—		%	3.59		%
Thereafter									2,050,000						2,050,000						—		%	2.41		%	—		%	2.41		%
Total						$2,113,600			$3,700,000			$84,784			$5,898,384						3.49		%	2.97		%	4.07		%	3.17		%
Total excluding asset sale term loan						$1,690,600			$3,700,000			$84,784			$5,475,384
Fixed rate debt balance 4						$675,000			$3,700,000			$84,784			$4,459,784

1On July 20, 2022, Legacy HR and Legacy HTA merged, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Balances are reflected net of discounts, fair value adjustments, and deferred financing costs and include premiums.

3Includes extension options.

4Reflects $675.0 million of interest rate swaps.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 12

Debt Covenants & Liquidity1

DOLLARS IN THOUSANDS

SELECTED FINANCIAL DEBT COVENANTS YEAR ENDED SEPTEMBER 30, 2022 2
			CALCULATION			REQUIREMENT			PER DEBT COVENANTS
Revolving credit facility and term loan
Leverage ratio			Total debt/total capital			Not greater than 60%			39.3		%
Secured leverage ratio			Total secured debt/total capital			Not greater than 30%			0.6		%
Unencumbered leverage ratio			Unsecured debt/unsecured real estate			Not greater than 60%			41.5		%
Fixed charge coverage ratio			EBITDA/fixed charges			Not less than 1.50x			4.2x
Unsecured coverage ratio			Unsecured EBITDA/unsecured interest			Not less than 1.75x			4.3x
Asset investments			Unimproved land, JVs & mortgages/total assets			Not greater than 35%			6.2		%
Senior Notes due 2030 and 2031 3
Incurrence of total debt			Total debt/total assets			Not greater than 60%			39.1		%
Incurrence of debt secured by any lien			Secured debt/total assets			Not greater than 40%			0.6		%
Maintenance of total unsecured assets			Unencumbered assets/unsecured debt			Not less than 150%			253.1		%
Debt service coverage			EBITDA/interest expense			Not less than 1.5x			3.5x
Other Senior Notes 4
Incurrence of total debt			Total debt/total assets			Not greater than 60%			40.3		%
Incurrence of debt secured by any lien			Secured debt/total assets			Not greater than 40%			0.6		%
Maintenance of total unsecured assets			Unencumbered assets/unsecured debt			Not less than 150%			244.4		%
Debt service coverage			EBITDA/interest expense			Not less than 1.5x			3.4x
Other
Net debt to adjusted EBITDA 5			Net debt (debt less cash)/adjusted EBITDA			Not required			6.3x
Net debt to enterprise value 6			Net debt/enterprise value			Not required			42.4		%

LIQUIDITY SOURCES
Cash			$57,583
Unsecured credit facility availability			1,309,400
Consolidated unencumbered assets (gross) 7			14,180,746

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Does not include all financial and non-financial covenants and restrictions that are required by the Company's various debt agreements. Financial measures include the Company's proportionate share of unconsolidated joint ventures, as applicable.

3The financial covenants for the Senior Note due 2030 exclude the impact of Topic 842, Lease Accounting from the financial covenant calculations.

4The senior note covenants calculations apply to the Senior Notes due 2025 and 2028. The Senior Notes due 2023 have similar covenants but contain a less restrictive definition of total assets.

5Adjusted EBITDA is based on the proforma full quarter results, annualized. See page 24 for a reconciliation of adjusted EBITDA. Proforma adjusted EBITDA and net debt includes run-rate adjustments highlighted on page 5.

6Based on the closing price of $20.85 on September 30, 2022 and 380,572,290 shares outstanding.

7Annualized third quarter 2022 unencumbered asset NOI was $819.2 million.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 13

Investment Activity

DOLLARS IN THOUSANDS

ACQUISITION ACTIVITY
MARKET			COUNT												SQUARE FEET			LEASED %			PURCHASE PRICE 1			% OWNERSHIP			CAP RATE
Q1 2022 total			9												398,520			87		%	223,150			77		%	4.7		%
Q2 2022 total			13												359,706			100		%	163,762			100		%	5.7		%
Q3 2022 total			8												242,602			98		%	91,253			100		%	5.6		%
YTD total			30												1,000,828			94		%	$478,165			89		%	5.3		%
JV Contribution																					(50,488)
YTD total, net																					$427,677
YTD average cap rate 2																					5.3		%

Q3 2022 ACQUISITION DETAIL
MARKET			COUNT			MILES TO CAMPUS			ASSOCIATED HEALTH SYSTEM/TENANCY			CLOSING			SQUARE FEET			LEASED %			PURCHASE PRICE 1			% OWNERSHIP
Seattle, WA			1			0.24			EvergreenHealth			8/1/2022			10,593			100		%	4,850			100		%
Raleigh, NC			1			0.24			WakeMed			8/9/2022			11,345			82		%	3,783			100		%
Jacksonville, FL			1			0.03			Ascension			8/9/2022			34,133			100		%	18,195			100		%
Atlanta, GA			1			0.11			Wellstar			8/10/2022			43,496			100		%	11,800			100		%
Denver, CO			1			2.10			Centura			8/11/2022			34,785			100		%	14,800			100		%
Raleigh, NC			1			0.19			Duke			8/18/2022			31,318			93		%	11,375			100		%
Nashville, TN			1			0.80			Ascension			9/15/2022			61,932			100		%	21,000			100		%
Austin, TX			1			0.03			HCA			9/29/2022			15,000			100		%	5,450			100		%
Q3 2022 total			8												242,602			98		%	$91,253
Subsequent activity
Jacksonville, FL			1			0.10			Ascension			10/12/2022			6,200			100		%	3,600			100		%

DISPOSITION ACTIVITY
LOCATION			COUNT			CLOSING			SQUARE FEET			LEASED %			SALE PRICE
Loveland, CO			2			2/24/2022			150,291			82		%	$84,950
San Antonio, TX			2			4/15/2022			201,523			51		%	25,500
Santa Fe, NM 5			1			7/18/2022			34,003			19		%	3,950
GA, FL, PA			4			7/29/2022			316,739			100		%	133,100
GA, FL, TX			6			8/4/2022			343,545			89		%	160,917
Los Angeles, CA 3			4			8/5/2022			283,780			67		%	134,845
Dallas, TX 4			6			8/30/2022			189,385			100		%	114,290
Indianapolis, IN			5			8/31/2022			506,406			99		%	238,845
Dallas, TX			2			10/4/2022			291,328			82		%	104,025
Houston, TX			1			10/21/2022			134,910			71		%	32,000
YTD total			33						2,451,910			84		%	$1,032,422
YTD average cap rate 6															4.6		%

1Includes joint venture acquisitions at full acquisition price.

2For acquisitions, cap rate represents the forecasted first year NOI divided by purchase price. Does not include fees earned related to the unconsolidated joint venture.

3The Company sold 80% of these properties into an unconsolidated joint venture.

4The Company sold 60% of these properties into an unconsolidated joint venture.

5Legacy HTA asset that was sold prior to the merger in July.

6For dispositions, cap rate represents the in-place cash NOI divided by sales price.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 14

Re/development Activity

DOLLARS IN THOUSANDS

RE/DEVELOPMENT PROJECTS
MARKET			ASSOCIATED HEALTH SYSTEM						SQUARE FEET			CURRENT LEASED %			BUDGET			COST TO COMPLETE			PROJECT START			ESTIMATED COMPLETION
Active development
Nashville, TN			Ascension						106,194			50		%	$44,000			$28,656			2Q 2021			3Q 2023
Orlando, FL 1			Advent Health						156,566			74		%	65,000			54,403			1Q 2022			2Q 2024
Raleigh, NC			UNC REX Health						120,694			—		%	49,300			34,050			2Q 2022			4Q 2024
Total development									383,454			44		%	$158,300			$117,109
Projected stabilized yield - 6.5%-7.5%
Active redevelopment
Seattle, WA 2			MultiCare						56,000			100		%	$12,500			$2,198			1Q 2021			4Q 2022
Dallas, TX			Baylor Scott & White						217,114			61		%	17,500			6,394			4Q 2020			4Q 2023
Washington, DC			Inova Health						259,290			62		%	21,200			19,163			1Q 2022			2Q 2024
Total redevelopment									532,404			66		%	$51,200			$27,755
Projected stabilized yield - 8.0%-11.0%
Total active re/development projects						915,858			57		%	$209,500			$144,864

PROSPECTIVE RE/DEVELOPMENT
MARKET			TYPE			SQUARE FEET 3			LEASED % 4			BUDGET			EXPECTED START			PROJECT DESCRIPTION
Fort Worth, TX			Dev			102,000			40		%	$48,000			2H 2023			New on-campus MOB
Orlando, FL			Dev			45,000			100		%	25,900			2H 2023			Phase one of a two phase development
Houston, TX			Dev			112,000			60		%	53,200			2H 2024			New on-campus MOB
Denver, CO			Dev			230,000			100		%	150,000			2H 2024			New surgical facility and MOB adjacent to campus
Houston, TX			Redev			297,423			61		%	20,275			2H 2023			Redevelopment of two on-campus MOBs
Chicago, IL			Redev			73,657			55		%	10,962			2H 2023			Redevelopment of an MOB in Chicago
Washington, DC			Redev			57,323			79		%	10,078			2H 2023			Off-campus MOB redevelopment
Total prospective re/development						917,403			71		%	$318,415

1Investment is a construction loan with purchase rights upon completion.

2Redevelopment project is a 23,000 square foot expansion to an existing medical office building. When complete, the building will be approximately 56,000 square feet.

3If project is identified as development (dev), then amount is projected building size. If project is a redevelopment (redev), then amount is existing building size.

4If project is identified as dev, then amount is expected preleasing percentage. If project is a redev, then amount is equal to current actual leased percentage.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 15

Portfolio 1,2,3

DOLLARS IN THOUSANDS

MARKETS
									WHOLLY OWNED COUNT						SQUARE FEET																								WHOLLY OWNED
MARKET			MSA RANK												MOB									INPATIENT/SURGICAL			OFFICE						WHOLLY OWNED			JOINT VENTURES			TOTAL			% OF NOI			CUMULATIVE % OF NOI
Dallas, TX			4									45						3,307,773									302,764			199,800						3,810,337			189,385			3,999,722			9.6		%	9.6		%
Seattle, WA			15						29						1,569,388																		1,569,388						1,569,388			5.7		%	15.3		%
Houston, TX			5						33						2,376,134									150,723			57,170						2,584,027						2,584,027			4.7		%	20.0		%
Los Angeles, CA			2						23						1,218,579									63,000			104,377						1,385,956			702,453			2,088,409			4.7		%	24.7		%
Atlanta, GA			9						37						1,826,752																		1,826,752						1,826,752			4.4		%	29.1		%
Boston, MA			11						18						964,945																		964,945						964,945			4.3		%	33.4		%
Charlotte, NC			22						32						1,790,415																		1,790,415						1,790,415			4.1		%	37.5		%
Denver, CO			19						32						1,741,127												93,869						1,834,996			116,616			1,951,612			4.1		%	41.6		%
Miami, FL			7						23						1,414,085									133,500									1,547,585						1,547,585			3.8		%	45.4		%
Phoenix, AZ			10						35						1,512,304																		1,512,304						1,512,304			2.7		%	48.1		%
Tampa, FL			18						20						1,012,094																		1,012,094						1,012,094			2.7		%	50.8		%
Raleigh, NC			42						27						1,103,636																		1,103,636						1,103,636			2.5		%	53.3		%
Nashville, TN			36						12						1,135,640												108,691						1,244,331						1,244,331			2.4		%	55.7		%
Austin, TX			29						13						861,481																		861,481						861,481			2.3		%	58.0		%
Indianapolis, IN			33						36						1,080,947									61,398									1,142,345			273,479			1,415,824			2.2		%	60.2		%
Chicago, IL			3						7						712,644																		712,644						712,644			2.2		%	62.4		%
Hartford, CT			48						30						768,947																		768,947						768,947			2.1		%	64.5		%
New York, NY			1						14						614,522																		614,522						614,522			1.8		%	66.3		%
Orlando, FL			23						8						359,477									186,998									546,475						546,475			1.8		%	68.1		%
Washington, DC			6						9						692,107																		692,107						692,107			1.7		%	69.8		%
Other (51 markets)									212						11,286,401									629,392			1,224,943						13,140,736			630,776			13,771,512			30.2		%	100.0		%
Total									695						37,349,398									1,527,775			1,788,850						40,666,023			1,912,709			42,578,732			100.0		%
Number of properties															665									20			10						695			33			728
% of square feet															91.8		%							3.8		%	4.4		%				100.0		%
% multi-tenant															84.0		%							—		%	61.8		%				81.6		%
Investment															$12,796,986									$666,409			$501,164						$13,964,559
Quarterly cash NOI 5															$184,560									$12,105			$7,249						$203,914
% of cash NOI															90.5		%							5.9		%	3.6		%				100.0		%

BY BUILDING TYPE
			WHOLLY OWNED
			MULTI-TENANT			SINGLE-TENANT			SUBTOTAL			JOINT VENTURE 5			TOTAL
Number of properties			547			148			695			33			728
Square feet			32,493,976			8,172,047			40,666,023			1,912,709			42,578,732
% of square feet			76.3		%	19.2		%	95.5		%	4.5		%	100.0		%
Investment 2			$10,573,019			$3,391,540			$13,964,559			$459,845			$14,424,404
Quarterly cash NOI 2,4			$151,048			$52,866			$203,914			$3,922			$207,836
% of cash NOI			72.7		%	25.4		%	98.1		%	1.9		%	100.0		%

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Gross investment and quarterly cash NOI are reflected at the Company's ownership percentage.

3Excludes assets held for sale, land held for development, construction in progress and corporate property.

4Includes Legacy HTA on a full quarter proforma basis.

5The Company's weighted average ownership percentage in its joint ventures was approximately 49%.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 16

Health Systems 1,2

MOB PORTFOLIO
									BUILDING SQUARE FEET												LEASED BY HEALTH SYSTEM			% OF LEASED SF
HEALTH SYSTEM			SYSTEM RANK 3			CREDIT RATING			ON/ADJACENT 4			OFF-CAMPUS AFFILIATED 5			TOTAL			% OF NOI 6
HCA Healthcare			1			BBB-/Baa3			2,431,873			734,759			3,166,632			8.7		%							831,004			2.3		%
CommonSpirit Health			4			A-/Baa1			1,906,957			593,550			2,500,507			6.6		%	880,442			2.5		%
Baylor Scott & White Health			21			AA-Aa3			2,570,180			66,376			2,636,556			6.1		%	1,670,906			4.7		%
Ascension Health			3			AA+/Aa2			2,147,950			97,551			2,245,501			5.4		%	942,610			2.6		%
Tenet Healthcare			6			B+/B2			1,525,855			414,278			1,940,133			4.3		%	503,670			1.4		%
Atrium Health			16			AA-/Aa3			682,654			348,792			1,031,446			3.2		%	907,825			2.5		%
Community Health Systems			8			CCC+/Caa2			1,024,527			—			1,024,527			3.0		%	391,827			1.1		%
AdventHealth			11			AA/Aa2			797,587			118,585			916,172			2.6		%	410,916			1.2		%
Wellstar Health System			75			A/A2			896,773			23,088			919,861			2.4		%	563,458			1.6		%
UW Medicine (Seattle)			91			AA+/Aaa			461,363			169,709			631,072			2.4		%	292,712			0.8		%
Trinity Health			7			AA-/Aa3			633,711			154,009			787,720			2.0		%	493,502			1.4		%
Baptist Memorial Health Care			89			BBB+/--			544,122			252,414			796,536			1.9		%	439,510			1.2		%
Providence St. Joseph Health			5			AA-/A1			330,287			31,601			361,888			1.5		%	267,053			0.7		%
Banner Health			24			AA-/--			749,075			31,039			780,114			1.4		%	147,178			0.4		%
Cedars-Sinai Health Systems			51			--/Aa3			199,701			90,607			290,308			1.4		%	52,891			0.1		%
Hawaii Pacific Health			181			--/A1			173,502			124,925			298,427			1.3		%	97,735			0.3		%
Overlake Health System			291			A/A2			230,710			—			230,710			1.2		%	73,676			0.2		%
Medstar Health			45			A/A2			322,033			—			322,033			1.2		%	223,965			0.6		%
Bon Secours Health System			22			A+/A1			405,945			—			405,945			1.1		%	236,637			0.7		%
Wakemed			185			--/A2			368,046			101,597			469,643			1.1		%	114,435			0.3		%
Indiana University Health			26			AA/Aa2			175,499			269,320			444,819			1.1		%	376,076			1.1		%
Other (65 credit rated systems)									6,516,945			2,993,071			9,510,016			23.7		%	4,303,034			12.1		%
Subtotal - credit rated 7									25,095,295			6,615,271			31,710,566			83.6		%	14,221,062			39.8		%
Other non-credit rated 8									1,162,849			404,076			1,566,925			5.7		%	861,170			2.4		%
Off-campus non-affiliated 9									—			4,071,907			4,071,907			10.7		%	49,919			0.1		%
Wholly-owned									26,258,144			11,091,254			37,349,398			100.0		%	15,132,151			42.3		%
Joint ventures									1,143,456			579,868			1,723,324
Total									27,401,600			11,671,122			39,072,722

1On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.

2Includes joint venture properties at total square feet. Excludes construction in progress and assets classified as held for sale.

3Ranked by revenue based on Modern Healthcare's Healthcare Systems Financials Database.

4The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.

5Includes off-campus buildings where health systems lease 20% or more of the property and are located within 2 miles from a hospital campus.

6Includes Legacy HTA on a full quarter proforma basis.

7Based on square footage, 76.4% is associated and 42.2% is leased by an investment-grade rated healthcare provider.

8Includes nine properties associated with a hospital system that is not credit rated.

9Includes off-campus buildings that are not anchored by a health system and are more than two miles from a hospital campus.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 17

MOB Proximity to Hospital 1,2

MEDICAL OFFICE BUILDINGS BY LOCATION
									WHOLLY-OWNED			JOINT VENTURE			TOTAL
On campus									45.6		%	55.8		%	46.0		%
Adjacent to campus 3									24.7		%	10.6		%	24.1		%
Total on/adjacent									70.3		%	66.4		%	70.1		%
Off campus - anchored by health system 4									11.4		%	7.1		%	11.2		%
Off campus									18.3		%	26.5		%	18.7		%
									100.0		%	100.0		%	100.0		%
Square feet									37,349,398			1,723,324			39,072,722
% of total									95.6		%	4.4		%	100.0		%

DISTANCE TO HOSPITAL CAMPUS
																								GROUND LEASE PROPERTIES
GREATER THAN			LESS THAN OR EQUAL TO			CAMPUS PROXIMITY			# OF PROPERTIES			SQUARE FEET			% OF TOTAL			CUMULATIVE %						# OF PROPERTIES			SQUARE FEET			% OF TOTAL
			0.00			On campus			231			17,990,046			46.0		%	46.0		%				180			14,231,683			81.0		%
0.00			0.25 miles			Adjacent 3			205			9,411,554			24.1		%	70.1		%				30			1,529,970			8.7		%
0.25 miles			2.00			Affiliated			102			5,183,814			13.3		%	83.4		%				12			824,896			4.7		%
2.00						Off campus			154			6,487,308			16.6		%	100.0		%	19			980,809			5.6		%
Totals									692			39,072,722			100.0		%							241			17,567,358			100.0		%
Wholly-owned									665			37,349,398
Joint ventures									27			1,723,324

1Includes joint venture properties and excludes construction in progress and assets classified as held for sale.

2Proximity to hospital campus includes acute care hospitals with inpatient beds. The Company does not consider inpatient rehab hospitals (IRFs), skilled nursing facilities (SNFs) or long-term acute care hospitals (LTACHs) to be hospital campuses for distance calculations.

3The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.

4Includes buildings where health systems lease 20% or more of the property.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 18

Lease Maturity & Occupancy1

LEASE MATURITY SCHEDULE
			MULTI-TENANT 2						SINGLE-TENANT						TOTAL
			# OF LEASES			SQUARE FEET			# OF LEASES			SQUARE FEET			# OF LEASES			SQUARE FEET			% OF LEASED SQUARE FEET
2022			475			1,184,604			2			107,886			477			1,292,490			3.6		%
2023			1,237			3,875,183			12			725,347			1,249			4,600,530			12.9		%
2024			1,146			4,239,202			18			914,693			1,164			5,153,895			14.4		%
2025			981			3,465,089			16			863,089			997			4,328,178			12.1		%
2026			805			3,120,939			9			485,445			814			3,606,384			10.1		%
2027			746			3,083,335			23			1,364,498			769			4,447,833			12.5		%
2028			389			1,719,074			15			662,660			404			2,381,734			6.7		%
2029			358			1,664,703			15			752,632			373			2,417,335			6.8		%
2030			267			1,539,505			13			625,890			280			2,165,395			6.1		%
2031			223			964,498			3			229,223			226			1,193,721			3.3		%
Thereafter			422			2,842,656			21			1,270,835			443			4,113,491			11.5		%
Total leased			7,049			27,698,788			147			8,002,198			7,196			35,700,986			87.8		%
Total building						32,493,976						8,172,047						40,666,023
Occupancy						85.2		%				97.9		%				87.8		%
WALTR (months) 3						50.6						71.7						55.3
WALT (months) 3						95.3						146.7						106.8

PORTFOLIO OCCUPANCY AND ABSORPTION
									OCCUPANCY %									ABSORPTION
			# OF PROPERTIES			SQUARE FEET			Q3 2022			Q2 2022			Q3 2021			SEQUENTIAL			Y-O-Y
Same store multi-tenant			456			27,316,594			86.2		%	86.2		%	85.5		%	2			196
Same store single-tenant			133			7,414,773			99.5		%	99.5		%	99.9		%	—			(29)
Total same store properties			589			34,731,367			89.1		%	89.1		%	88.6		%	2			167
Acquisitions			85			4,234,607			89.3		%	89.6		%	88.2		%	(14)			29
Development completions			6			409,801			86.8		%	82.6		%	79.8		%	17			29
Re/development			11			1,067,458			58.4		%	63.9		%	76.3		%	(59)			(191)
Planned dispositions			4			222,790			2.4		%	25.1		%	26.5		%	(51)			(54)
Wholly-owned			695			40,666,023			87.8		%	88.0		%	87.8		%	(105)			(20)
Joint ventures			33			1,912,709			85.5		%	87.2		%	88.5		%	8			6
Total			728			42,578,732			87.7		%	88.0		%	87.8		%	(97)			(14)

1Excludes joint ventures land held for development, construction in progress, corporate property and assets classified as held for sale.

2The average lease size in the multi-tenant portfolio is 3,929 square feet.

3WALTR = weighted average lease term remaining; WALT = weighted average lease term.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 19

Leasing Statistics 1

REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS

SAME STORE 3Q 2022 RENEWALS
			Q3 2022			TTM
Cash leasing spreads			2.9		%	2.3		%
Cash leasing spreads distribution
< 0% spread			10.1		%	12.7		%
0-3% spread			25.7		%	24.4		%
3-4% spread			42.5		%	42.6		%
> 4% spread			21.7		%	20.3		%
Total			100.0		%	100.0		%
Tenant retention rate			79.1		%	80.2		%

AVERAGE IN-PLACE CONTRACTUAL INCREASES 2
			MULTI-TENANT									SINGLE-TENANT									TOTAL
			% INCREASE			% OF BASE RENT						% INCREASE			% OF BASE RENT						% INCREASE			% OF BASE RENT
Same store			2.75		%	63.0		%				2.28		%	19.4		%				2.64		%	82.4		%
Acquisitions			2.40		%	10.6		%				2.59		%	1.9		%				2.43		%	12.6		%
Other 3			2.52		%	4.0		%				1.23		%	1.0		%				2.24		%	5.0		%
Total			2.69		%	77.6		%				2.25		%	22.4		%				2.60		%	100.0		%
Escalator type
Fixed			2.73		%	96.6		%				2.38		%	84.6		%				2.66		%	93.9		%
CPI			1.78		%	3.4		%				1.57		%	15.4		%				1.66		%	6.1		%

TYPE AND OWNERSHIP STRUCTURE
			MULTI-TENANT			SINGLE-TENANT						TOTAL
Tenant type
Hospital			44.9		%	74.0		%				51.4		%
Physician and other			55.1		%	26.0		%				48.6		%
Lease structure
Gross			8.6		%	6.4		%				8.1		%
Modified gross			32.2		%	9.3		%				27.0		%
Net			59.2		%	53.2		%				57.9		%
Absolute net 4			—		%	31.1		%				7.0		%
Ownership type
Ground lease			45.0		%	31.1		%				42.2		%
Fee simple			55.0		%	68.9		%				57.8		%

# OF LEASES BY SIZE
LEASED SQUARE FEET			MULTI-TENANT			SINGLE-TENANT
0 - 2,500			3,760			—
2,501 - 5,000			1,765			2
5,001 - 7,500			615			5
7,501 - 10,000			321			6
10,001 +			588			134
Total Leases			7,049			147

1Excludes recently acquired or disposed properties, construction in progress, land held for development, corporate property, planned dispositions and assets classified as held for sale.

2Excludes leases with lease terms of one year or less.

3Includes redevelopment properties, development completions, and joint ventures.

4Tenant is typically responsible for operating expenses and capital obligations.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 20

NOI Performance 1

DOLLARS IN THOUSANDS, EXCEPT PER SQUARE FOOT DATA

REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS

SAME STORE CASH NOI
			TTM 2022						3Q 2022			2Q 2022			1Q 2022			4Q 2021						TTM 2021						3Q 2021			2Q 2021			1Q 2021			4Q 2020
Base revenue			$846,256						$214,096			$211,551			$211,481			$209,128						$824,435						$207,385			$205,798			$204,970			$206,282
Operating expense recoveries			246,903						64,710			61,215			62,724			58,254						231,516						58,316			57,961			58,896			56,343
Revenues			$1,093,159						$278,806			$272,766			$274,205			$267,382						$1,055,951						$265,701			$263,759			$263,866			$262,625
Expenses			379,253						99,978			92,983			96,672			89,620						358,624						91,750			88,514			89,967			88,393
Cash NOI			$713,906						$178,828			$179,783			$177,533			$177,762						$697,327						$173,951			$175,245			$173,899			$174,232
Revenue per occ SF 2			$35.43						$36.05			$35.33			$35.58			$34.73						$34.16						$34.54			$34.24			$34.11			$33.78
Margin			65.3		%				64.1		%	65.9		%	64.7		%	66.5		%				66.0		%				65.5		%	66.4		%	65.9		%	66.3		%
Average occupancy			88.8		%				89.1		%	88.9		%	88.8		%	88.7		%				89.0		%				88.6		%	88.7		%	89.1		%	89.5		%
Period end occupancy			89.1		%				89.1		%	89.1		%	88.8		%	88.8		%				88.6		%				88.6		%	88.6		%	88.8		%	89.4		%
Number of properties			589						589			589			589			589						589						589			589			589			589

SAME STORE GROWTH
			YEAR-OVER-YEAR
			TTM 2022						3Q 2022			2Q 2022			1Q 2022			4Q 2021
Revenue per occ SF 2			3.7		%				4.4		%	3.2		%	4.3		%	2.8		%
Avg occupancy (bps)			-20						+50			+20			-30			-80
Revenues			3.5		%				4.9		%	3.4		%	3.9		%	1.8		%
Base revenue			2.6		%				3.2		%	2.8		%	3.2		%	1.4		%
Exp recoveries			6.6		%				11.0		%	5.6		%	6.5		%	3.4		%
Expenses			5.8		%				9.0		%	5.0		%	7.5		%	1.4		%
Cash NOI			2.4		%				2.8		%	2.6		%	2.1		%	2.0		%

TOTAL CASH NOI
			3Q 2022			3Q 2021			% CHANGE						TTM 2022			TTM 2021			% CHANGE
Same store cash NOI			$178,828			$173,951			2.8		%				$713,906			$697,327			2.4		%
Same store joint ventures			1,152			1,062			8.5		%				4,512			4,398			2.6		%
			179,980			175,013			2.8		%				718,418			701,725			2.4		%
Redevelopment			2,792			4,765			(41.4		%)				12,214			17,943			(31.9		%)
Acquisitions/development completions			22,815			9,623			137.1		%				76,836			21,686			254.3		%
Dispositions/assets held for sale/other			7,033			16,368			(57.0		%)				49,819			73,407			(32.1		%)
Joint venture property cash NOI			2,770			1,170			136.8		%				8,640			2,746			214.6		%
Cash NOI			$215,390			$206,939			4.1		%				$865,927			$817,507			5.9		%

1Excludes recently acquired or disposed properties, development completions, construction in progress, land held for development, corporate property, reposition properties and assets classified as held for sale.

2Revenue per occ SF is calculated by dividing revenue by the average of the occupied SF for the period provided. Quarterly revenue per occ SF is annualized.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 21

NOI Reconciliations

DOLLARS IN THOUSANDS

BOTTOM UP RECONCILIATION
			3Q 2022			2Q 2022			1Q 2022			4Q 2021												3Q 2021			2Q 2021			1Q 2021			4Q 2020
Net income (loss)			$28,304			$6,130			$42,227			$21,607												($2,066)			$23,096			$24,022			($15,863)
Non-controlling interests			312			—			—			—												—			—			—			—
Other income (expense)			(89,477)			7,479			(29,293)			(468)												23,000			(2,223)			(5,220)			35,284
General and administrative expense			16,741			10,540			11,036			8,901												8,207			8,545			8,499			7,206
Depreciation and amortization expense			158,117			55,731			54,041			51,810												50,999			49,826			50,079			48,104
Other expenses 1			82,659			11,034			9,929			3,850												3,193			2,840			2,783			2,919
Straight-line rent expense			1,260			378			378			382												380			369			367			369
Straight-line rent revenue			(8,975)			(1,705)			(1,587)			(1,227)												(1,550)			(1,563)			(1,461)			(1,013)
Other revenue 2			(5,242)			(1,961)			(2,044)			(2,134)												(2,043)			(2,075)			(1,865)			(2,145)
Joint venture property cash NOI			3,922			2,551			2,052			1,331												1,210			1,035			465			135
Cash NOI			$187,621			$90,177			$86,739			$84,052												$81,330			$79,850			$77,669			$74,996
Pre-merger Legacy HTA NOI			27,769			130,788			129,476			129,305												125,609			126,311			126,278			125,464
Proforma Cash NOI			$215,390			$220,965			$216,215			$213,357												$206,939			$206,161			$203,947			$200,460
Acquisitions/development completions			(22,815)			(22,026)			(18,027)			(13,968)												(9,623)			(6,467)			(4,747)			(849)
Dispositions/assets held for sale/other			(7,033)			(12,968)			(14,114)			(15,704)												(16,368)			(17,749)			(19,348)			(19,943)
Joint venture property cash NOI			(3,922)			(3,648)			(3,158)			(2,424)												(2,232)			(2,183)			(1,542)			(1,186)
Redevelopment			(2,792)			(2,540)			(3,383)			(3,499)												(4,765)			(4,517)			(4,411)			(4,250)
Proforma Same store cash NOI			$178,828			$179,783			$177,533			$177,762												$173,951			$175,245			$173,899			$174,232
TOP DOWN RECONCILIATION
			3Q 2022			2Q 2022			1Q 2022			4Q 2021												3Q 2021			2Q 2021			1Q 2021			4Q 2020
Rental income before rent concessions			$301,692			$142,073			$139,775			$132,853												$132,971			$129,609			$129,466			$124,537
Rent concessions			(2,761)			(1,441)			(1,286)			(1,139)												(1,225)			(1,123)			(1,077)			(660)
Rental income			298,931			140,632			138,489			131,714												131,746			128,486			128,389			123,877
Parking income			2,428			1,919			1,753			2,134												2,187			1,880			1,658			1,678
Interest from financing receivable, net			2,034			1,957			1,930			1,766												1,917			510			—			—
Exclude straight-line rent revenue			(8,975)			(1,705)			(1,587)			(1,227)												(1,550)			(1,563)			(1,461)			(1,013)
Exclude other non-cash revenue 3			(2,280)			(1,142)			(1,322)			(1,325)												(1,261)			(1,528)			(1,573)			(1,820)
Cash revenue			292,138			141,661			139,263			133,062												133,039			127,785			127,013			122,722
Property operating expense			(112,473)			(57,010)			(57,464)			(53,032)												(55,518)			(51,509)			(52,215)			(50,210)
Exclude non-cash expenses 4			4,034			2,975			2,888			2,691												2,599			2,539			2,406			2,349
Joint venture property cash NOI			3,922			2,551			2,052			1,331												1,210			1,035			465			135
Cash NOI			$187,621			$90,177			$86,739			$84,052												$81,330			$79,850			$77,669			$74,996
Pre-merger Legacy HTA NOI			27,769			130,788			129,476			129,305												125,609			126,311			126,278			125,464
Proforma Cash NOI			$215,390			$220,965			$216,215			$213,357												$206,939			$206,161			$203,947			$200,460
Acquisitions/development completions			(22,815)			(22,026)			(18,027)			(13,968)												(9,623)			(6,467)			(4,747)			(849)
Dispositions/assets held for sale/other			(7,033)			(12,968)			(14,114)			(15,704)												(16,368)			(17,749)			(19,348)			(19,943)
Joint venture property cash NOI			(3,922)			(3,648)			(3,158)			(2,424)												(2,232)			(2,183)			(1,542)			(1,186)
Redevelopment			(2,792)			(2,540)			(3,383)			(3,499)												(4,765)			(4,517)			(4,411)			(4,250)
Proforma Same store cash NOI			$178,828			$179,783			$177,533			$177,762												$173,951			$175,245			$173,899			$174,232

1Includes acquisition and pursuit costs, merger-related costs, bad debt, above and below market ground lease intangible amortization, leasing commission amortization, non-cash adjustments for financing receivables, and ground lease straight-line rent.

2Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease termination fees, deferred financing cost amortization and principle related to investment in financing receivable, and tenant improvement overage amortization.

3Includes above and below market lease intangibles, lease inducements, lease termination fees, deferred financing cost amortization, financing receivable adjustments, and TI amortization.

4Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 22

NOI Reconciliations

DOLLARS IN THOUSANDS

RECONCILIATION OF NOI TO PROFORMA FULL QUARTER FFO AND NORMALIZED FFO
			PROFORMA 3Q 2022			2Q 2022			1Q 2022			4Q 2021												3Q 2021			2Q 2021			1Q 2021			4Q 2020
Cash NOI			$215,390			$90,177			$86,739			$84,052												$81,330			$79,850			$77,669			$74,996
General and administrative expense			(18,956)			(10,540)			(11,036)			(8,901)												(8,207)			(8,545)			(8,499)			(7,206)
Straight-line rent			11,456			1,705			1,587			1,227												1,550			1,563			1,461			1,013
Interest and other income (expense), net			(172)			(125)			(81)			(250)												—			(262)			500			140
Management fees and other income			397			819			722			809												782			547			292			325
Note receivable interest income			1,332			—			—			—												—			—			—			—
Other non-cash revenue 1			2,781			1,142			1,322			1,325												1,261			1,528			1,573			1,820
Other non-cash expenses 2			(4,289)			(2,975)			(2,888)			(2,691)												(2,599)			(2,539)			(2,406)			(2,349)
Pre-merger Legacy HTA NOI			1,741			—			—			—												—			—			—			—
Unconsolidated JV adjustments			(520)			(51)			6			131												167			181			276			(73)
Debt Covenant EBITDA			$209,160			$80,152			$76,371			$75,702												$74,284			$72,323			$70,866			$68,666
Interest expense			(60,391)			(15,543)			(13,661)			(13,266)												(13,334)			(13,261)			(13,262)			(13,618)
Loss on extinguishment of debt			(1,091)			—			(1,429)			—												—			—			—			(21,503)
Acquisition and pursuit costs			(482)			(1,352)			(1,303)			(1,152)												(974)			(670)			(744)			(939)
Merger-related costs			(79,402)			(7,085)			(6,116)			(389)												—			—			—			—
Leasing commission amortization 3			2,731			2,683			2,600			2,382												2,294			2,258			2,111			2,033
Non-real estate depreciation and amortization			(1,243)			(1,080)			(983)			(937)												(903)			(885)			(879)			(886)
Unconsolidated JV adjustments			—			—			(34)			(37)												(2)			(8)			(2)			(8)
FFO			$69,282			$57,775			$55,445			$62,303												$61,365			$59,757			$58,090			$33,745
Acquisition and pursuit costs			482			1,352			1,303			1,152												974			670			744			939
Merger-related costs			79,402			7,085			6,116			389												—			—			—			—
Lease intangible amortization			127			584			309			192												48			(6)			(72)			(4)
Significant non-recurring legal fees/forfeited earnest money received			346			140			91			465												—			—			(500)			—
Debt financing costs			1,091			—			1,429			—												—			283			—			21,920
Unconsolidated JV normalizing items			154			83			95			90												54			55			27			16
Normalized FFO			$150,884			$67,019			$64,788			$64,591												$62,441			$60,759			$58,289			$56,616

1Includes above and below market lease intangibles, interest income related to sales-type leases, lease inducements, lease termination fees, deferred financing cost amortization, and principle related to investment in financing receivable and TI amortization.

2Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.

3Leasing commission amortization is included in the real estate depreciation and amortization add-back for FFO.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 23

EBITDA Reconciliations

DOLLARS IN THOUSANDS

REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS

RECONCILIATION OF EBITDA
			3Q 2022						2Q 2022
			AS REPORTED			PROFORMA FULL QUARTER			Combined			Legacy HR			Legacy HTA
Net income			$28,615			$21,533			$20,552			$6,130			$14,422
Interest expense			53,044			60,391			40,303			15,543			24,760
Depreciation and amortization			158,117			186,643			130,782			55,731			75,051
Unconsolidated JV depreciation and amortization			3,526			3,526			3,295			2,807			488
EBITDA			$243,302			$272,093			$194,932			$80,211			$114,721
Leasing commission amortization			2,731			2,731			2,683			2,683			—
Gain on sales of real estate properties			(143,908)			(143,908)			(8,496)			(8,496)			—
EBITDAre 1			$102,125			$130,916			$189,119			$74,398			$114,721
EBITDA			$243,302			$272,093			$194,932			$80,211			$114,721
Acquisition and pursuit costs			482			482			1,449			1,352			97
Merger-related costs			79,402			79,402			12,192			7,085			5,107
Gain on sales of real estate properties			(143,908)			(143,908)			(8,496)			(8,496)			—
Loss on extinguishment of debt			1,091			1,091			3,615			—			3,615
Debt Covenant EBITDA			$180,369			$209,160			$203,692			$80,152			$123,540
Leasing commission amortization			2,731			2,731			2,683			2,683			—
Lease intangible amortization			(2)			127			584			584			—
Acquisition/disposition timing impact 2			(1,155)			(3,079)			2,337			2,243			94
Stock based compensation			3,666			3,666			5,547			3,356			2,191
Other normalizing adjustments 3			—			—			1,702			—			1,702
Unconsolidated JV adjustments			154			154			83			83			—
Adjusted EBITDA			$185,763			$212,759			$216,628			$89,101			$127,527
Run-rate adjustments
October asset sales 5						(1,625)
Expected November asset sales 6						(1,400)
Expected December asset sales 7						(3,000)
Seasonal utilities						2,500
Expected G&A synergies						4,500
Total run-rate adjustments						$975
Run-rate adjusted EBITDA						$213,734

1Earnings before interest, taxes, depreciation and amortization for real estate ("EBITDAre") is an operating performance measure adopted by NAREIT. NAREIT defines EBITDAre equal to “net income (computed in accordance with GAAP) plus interest expense, income tax expense, depreciation and amortization, impairments and minus gains on the disposition of depreciated property.”

2Adjusted to reflect quarterly EBITDA from properties acquired or disposed in the quarter.

3For the three months ended June 30, 2022, other normalizing adjustments for Legacy HTA include the following: (i) legal and professional fees related to the whistleblower investigation and other audit committee matters of $1.0 million; and (ii) net costs related to nonrecurring legal and tenant matters of $0.7 million. For the six months ended June 30, 2022, other normalizing adjustments include the following: (i) legal and professional fees related to the whistleblower investigation and other audit committee matters of $1.1 million; (ii) net costs related to nonrecurring legal and tenant matters of $0.8 million; (iii) additional board meeting fees of $0.2 million; and (iv) professional fees related to strategic review matters of $0.1 million.

4FFO and EBITDA includes the impact of straight-line rent.

5Reflects NOI loss related to dispositions of $136.0 million that occurred in October.

6Reflects NOI loss related to dispositions of $105.0 million that are expected to occur in November.

7Reflects NOI loss related to dispositions of $182.0 million that are expected to occur in December.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 24

Components of Net Asset Value

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

REFLECTS COMBINED COMPANY RESULTS

CASH NOI BY PROPERTY TYPE
			3Q 2022
ASSET TYPE			SAME STORE 1			ACQ./DEV. COMPLETIONS 2			JOINT VENTURE			REDEVELOPMENT			TIMING/OTHER ADJUSTMENTS 3			ADJUSTED CASH NOI						ANNUALIZED ADJUSTED NOI
MOB/outpatient			$159,106			$22,815			$3,663			$2,792			$3,586			$191,962						$767,848
Inpatient/Surgical			12,473			—			259			—			—			12,732						50,928
Office			7,249			—			—			—			—			7,249						28,996
Total Cash NOI			$178,828			$22,815			$3,922			$2,792			$3,586			$211,943						$847,772

DEVELOPMENT PROPERTIES									TOTAL SHARES OUTSTANDING
Land held for development			$73,321						As of November 4, 2022 8									384,615,283
Re/development budget			209,500
			$282,821						IMPLIED CAP RATE
															STOCK PRICE			IMPLIED CAP RATE
									As of November 4, 2022 8						$20.23			6.5		%
OTHER ASSETS									MERGER CLOSE TO SEPTEMBER 30, 2022:
Assets held for sale 4			$329,187						High						$26.84			5.4		%
Unstabilized properties 5			78,426						Low						$20.58			6.4		%
Cash and other assets 6			304,911
			$712,524
DEBT
Unsecured credit facility			$190,600
Asset sale term loan			423,000
Unsecured term loans			1,500,000
Senior notes			3,700,000
Mortgage notes payable			84,784
Remaining re/development funding			144,864
Other liabilities 7			255,012
			$6,298,260

1See NOI Performance schedule on page 21 for details on same store NOI.

2Adjusted to reflect quarterly NOI from properties acquired or stabilized re/developments completed during the full eight quarter period that are not included in same store NOI.

3Timing adjustments include current quarter acquisitions of $0.9 million as well as re/development completion adjustments of $0.5 million and seasonal expenses of $2.5 million to reflect full quarterly stabilized NOI. This is slightly offset by $0.3 million of negative NOI for unstabilized properties.

4Represents estimated gross purchase for six held for sale properties and four properties that the Company has identified for future disposition.

5Includes 12 properties comprising 353,000 square feet that generated negative NOI of $0.3 million at gross book value.

6Includes cash of $57.6 million, prepaid assets of $88.1 million, notes receivable of $79.0 million, accounts receivable of $39.8 million, prepaid ground leases of $19.3 million, and other investments of $6.0 million. In addition, includes the Company's occupied portion of its corporate headquarters in Nashville and Charleston of $15.1 million.

7Includes only liabilities that are expected to reduce future cash or NOI and that are currently producing non-cash benefits to NOI. Included are accounts payable and accrued liabilities of $225.7 million, security deposits of $28.7 million, and deferred operating expense reimbursements of $0.6 million.

8Total shares outstanding includes OP units and does not reflect the shares associated with forward equity contracts. As of September 30, 2022, the Company had no remaining shares to be settled under forward equity contracts.

HEALTHCARE REALTY 3Q 2022 SUPPLEMENTAL INFORMATION 25